Immediate Impact
61 standout
Citing Papers
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
2024 Standout
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers
2024 Standout
Works of Kathryn E. Marqueen being referenced
Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kathryn E. Marqueen | 109 | 59 | 66 | 20 | 209 | |
| O. Scheibe | 55 | 56 | 34 | 30 | 148 | |
| Yuta Sekino | 51 | 77 | 50 | 35 | 153 | |
| L. Ivarsson | 128 | 78 | 31 | 21 | 260 | |
| Gregory Rosenblatt | 96 | 96 | 70 | 24 | 293 | |
| Kun Xia | 72 | 62 | 58 | 17 | 143 | |
| G. Mantovani | 119 | 36 | 142 | 24 | 277 | |
| Donald M. Hayes | 44 | 22 | 77 | 21 | 286 | |
| Tomohisa Matsunaga | 61 | 60 | 77 | 21 | 193 | |
| Abhay Kumar | 101 | 161 | 21 | 22 | 274 | |
| Jan Pieter Pennings | 55 | 51 | 73 | 20 | 232 |
All Works
Login with ORCID to disown or claim papers
Loading papers...